| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abnormal liver tests in patients with SARS-CoV-2 or influenza – prognostic similarities and temporal disparities
|
Shafran, Noa
|
|
|
|
3 |
p.
|
artikel
|
| 2 |
Adverse muscle composition is a significant risk factor for all-cause mortality in NAFLD
|
Linge, Jennifer
|
|
|
|
3 |
p.
|
artikel
|
| 3 |
A human liver chimeric mouse model for non-alcoholic fatty liver disease
|
Bissig-Choisat, Beatrice
|
|
|
|
3 |
p.
|
artikel
|
| 4 |
A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection
|
Burm, Rani
|
|
|
|
3 |
p.
|
artikel
|
| 5 |
A nationwide population-based prospective study of cirrhosis in Iceland
|
Olafsson, Sigurdur
|
|
|
|
3 |
p.
|
artikel
|
| 6 |
Anticoagulation in the cirrhotic patient
|
Turco, Laura
|
|
2019
|
|
3 |
p. 227-239
|
artikel
|
| 7 |
Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis
|
Bhattacharya, Dipankar
|
|
|
|
3 |
p.
|
artikel
|
| 8 |
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
|
Muñoz-Martínez, Sergio
|
|
|
|
3 |
p.
|
artikel
|
| 9 |
Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injury
|
Iruzubieta, Paula
|
|
|
|
3 |
p.
|
artikel
|
| 10 |
Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper
|
Boettler, Tobias
|
|
|
|
3 |
p.
|
artikel
|
| 11 |
Cholangiocarcinoma across England: Temporal changes in incidence, survival and routes to diagnosis by region and level of socioeconomic deprivation
|
Tataru, Daniela
|
|
|
|
3 |
p.
|
artikel
|
| 12 |
Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosis
|
Cazzagon, Nora
|
|
|
|
3 |
p.
|
artikel
|
| 13 |
Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B
|
Buti, Maria
|
|
|
|
3 |
p.
|
artikel
|
| 14 |
Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammation
|
Kjærgaard, Kristoffer
|
|
|
|
3 |
p.
|
artikel
|
| 15 |
Combined alcoholic and non-alcoholic steatohepatitis
|
Ntandja Wandji, Line Carolle
|
|
|
|
3 |
p.
|
artikel
|
| 16 |
Contents
|
|
|
2019
|
|
3 |
p. iii
|
artikel
|
| 17 |
Contents
|
|
|
|
|
3 |
p.
|
artikel
|
| 18 |
Contents
|
|
|
|
|
3 |
p.
|
artikel
|
| 19 |
Contents
|
|
|
|
|
3 |
p.
|
artikel
|
| 20 |
Contents
|
|
|
|
|
3 |
p.
|
artikel
|
| 21 |
Contents
|
|
|
|
|
3 |
p.
|
artikel
|
| 22 |
Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation
|
Praktiknjo, Michael
|
|
|
|
3 |
p.
|
artikel
|
| 23 |
Copyright and Information
|
|
|
2019
|
|
3 |
p. e1
|
artikel
|
| 24 |
Copyright and information
|
|
|
|
|
3 |
p.
|
artikel
|
| 25 |
Copyright and information
|
|
|
|
|
3 |
p.
|
artikel
|
| 26 |
Copyright and information
|
|
|
|
|
3 |
p.
|
artikel
|
| 27 |
Copyright and information
|
|
|
|
|
3 |
p.
|
artikel
|
| 28 |
Copyright and information
|
|
|
|
|
3 |
p.
|
artikel
|
| 29 |
Corrigendum to “Expert management of congenital portosystemic shunts and their complications” [JHEP Reports 6 (2024)]
|
McLin, Valérie Anne
|
|
|
|
3 |
p.
|
artikel
|
| 30 |
Corrigendum to “Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales” [JHEP Reports 4 (2022)]
|
Bin Usman Shah, Syed Hassan
|
|
|
|
3 |
p.
|
artikel
|
| 31 |
CT-derived liver and spleen volume accurately diagnose clinically significant portal hypertension in patients with hepatocellular carcinoma
|
Romero-Cristóbal, Mario
|
|
|
|
3 |
p.
|
artikel
|
| 32 |
Decreased maximal cortisol secretion rate in patients with cirrhosis: Relation to disease severity
|
Lovato, Christina M.
|
|
|
|
3 |
p.
|
artikel
|
| 33 |
Defatting strategies in the current era of liver steatosis
|
Mazilescu, Laura Ioana
|
|
|
|
3 |
p.
|
artikel
|
| 34 |
Development and validation of circulating protein signatures as diagnostic biomarkers for biliary tract cancer
|
Christensen, Troels D.
|
|
|
|
3 |
p.
|
artikel
|
| 35 |
Differential blood transcriptome modules predict response to corticosteroid therapy in alcoholic hepatitis
|
Sharma, Shvetank
|
|
|
|
3 |
p.
|
artikel
|
| 36 |
Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatment
|
Gömer, André
|
|
|
|
3 |
p.
|
artikel
|
| 37 |
Editorial Board
|
|
|
2019
|
|
3 |
p. i
|
artikel
|
| 38 |
Editorial Board
|
|
|
|
|
3 |
p.
|
artikel
|
| 39 |
Editorial Board page
|
|
|
|
|
3 |
p.
|
artikel
|
| 40 |
Editorial Board page
|
|
|
|
|
3 |
p.
|
artikel
|
| 41 |
Editorial Board page
|
|
|
|
|
3 |
p.
|
artikel
|
| 42 |
Editorial Board page
|
|
|
|
|
3 |
p.
|
artikel
|
| 43 |
Enhancing ACLF prediction by integrating sarcopenia assessment and frailty in liver transplant candidates on the waiting list
|
Perdiguero, Gonzalo Gómez
|
|
|
|
3 |
p.
|
artikel
|
| 44 |
Evaluation of liver tumour response by imaging
|
Gregory, Jules
|
|
|
|
3 |
p.
|
artikel
|
| 45 |
Expert opinion on bleeding risk from invasive procedures in cirrhosis
|
Riescher-Tuczkiewicz, Alix
|
|
|
|
3 |
p.
|
artikel
|
| 46 |
Features and outcome of AIH patients without elevation of IgG
|
Hartl, Johannes
|
|
|
|
3 |
p.
|
artikel
|
| 47 |
Genetic or pharmacological reduction of cholangiocyte senescence improves inflammation and fibrosis in the Mdr2 -/- mouse
|
Alsuraih, Mohammed
|
|
|
|
3 |
p.
|
artikel
|
| 48 |
Genetic predisposition similarities between NASH and ASH: Identification of new therapeutic targets
|
Bianco, Cristiana
|
|
|
|
3 |
p.
|
artikel
|
| 49 |
HBeAg seroconversion is associated with a more effective PD-L1 blockade during chronic hepatitis B infection
|
Ferrando-Martinez, Sara
|
|
2019
|
|
3 |
p. 170-178
|
artikel
|
| 50 |
Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosis
|
McSweeney, Lorraine
|
|
|
|
3 |
p.
|
artikel
|
| 51 |
Hepatic bile acid transport increases in the postprandial state: A functional 11C-CSar PET/CT study in healthy humans
|
Ørntoft, Nikolaj W.
|
|
|
|
3 |
p.
|
artikel
|
| 52 |
Hepatitis C prevalences in the psychiatric setting: Cost-effectiveness of scaling-up screening and direct-acting antiviral therapy
|
Girardin, François
|
|
|
|
3 |
p.
|
artikel
|
| 53 |
Hepatitis C virus replication requires integrity of mitochondria-associated ER membranes
|
Duponchel, Sarah
|
|
|
|
3 |
p.
|
artikel
|
| 54 |
Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome
|
Van Wettere, Morgane
|
|
|
|
3 |
p.
|
artikel
|
| 55 |
Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD – Reconciling the present with the past
|
Ayonrinde, Oyekoya T.
|
|
|
|
3 |
p.
|
artikel
|
| 56 |
Identification of selective hepatitis delta virus ribozyme inhibitors by high-throughput screening of small molecule libraries
|
Tseligka, Eirini D.
|
|
|
|
3 |
p.
|
artikel
|
| 57 |
Impact of cirrhosis aetiology on incidence and prognosis of hepatocellular carcinoma diagnosed during surveillance
|
Ganne-Carrié, Nathalie
|
|
|
|
3 |
p.
|
artikel
|
| 58 |
Inborn and acquired risk factors for severe liver disease in Europeans with type 2 diabetes from the UK Biobank
|
Tavaglione, Federica
|
|
|
|
3 |
p.
|
artikel
|
| 59 |
Inducers of the NF-κB pathways impair hepatitis delta virus replication and strongly decrease progeny infectivity in vitro
|
Michelet, Maud
|
|
|
|
3 |
p.
|
artikel
|
| 60 |
Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis
|
Villeret, François
|
|
|
|
3 |
p.
|
artikel
|
| 61 |
Innovative liver research continues during the current pandemic
|
Francque, Sven
|
|
|
|
3 |
p.
|
artikel
|
| 62 |
Intrapancreatic fat deposition is unrelated to liver steatosis in metabolic dysfunction-associated steatotic liver disease
|
Mak, Anne Linde
|
|
|
|
3 |
p.
|
artikel
|
| 63 |
Is PD-1 blockade a potential therapy for HBV?
|
Féray, Cyrille
|
|
2019
|
|
3 |
p. 142-144
|
artikel
|
| 64 |
Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis
|
Torp, Nikolaj
|
|
|
|
3 |
p.
|
artikel
|
| 65 |
Liver cancer: A leading cause of cancer death in the United States and the role of the 1945–1965 birth cohort by ethnicity
|
Pinheiro, Paulo S.
|
|
2019
|
|
3 |
p. 162-169
|
artikel
|
| 66 |
Liver transplantation for late-onset presentations of acute liver failure in Wilson's disease: The UK experience over 2 decades
|
Shribman, Samuel
|
|
|
|
3 |
p.
|
artikel
|
| 67 |
Malignant transformation of hepatocellular adenoma
|
Julien, Céline
|
|
|
|
3 |
p.
|
artikel
|
| 68 |
Microbiota modulation by dietary oat beta-glucan prevents steatotic liver disease progression
|
Jaeger, Julius W.
|
|
|
|
3 |
p.
|
artikel
|
| 69 |
New insights on the role of vascular endothelial growth factor in biliary pathophysiology
|
Mariotti, Valeria
|
|
|
|
3 |
p.
|
artikel
|
| 70 |
New treatments/targets for primary biliary cholangitis
|
Corpechot, Christophe
|
|
2019
|
|
3 |
p. 203-213
|
artikel
|
| 71 |
Novel machine learning models outperform risk scores in predicting hepatocellular carcinoma in patients with chronic viral hepatitis
|
Wong, Grace Lai-Hung
|
|
|
|
3 |
p.
|
artikel
|
| 72 |
Nucleic acid biomarkers to assess graft injury after liver transplantation
|
Bardhi, Elissa
|
|
|
|
3 |
p.
|
artikel
|
| 73 |
Odevixibat treatment in an adult patient with advanced icteric progressive cholestatic liver disease
|
Herta, Toni
|
|
|
|
3 |
p.
|
artikel
|
| 74 |
Opioid epidemic and liver disease
|
Verna, Elizabeth C.
|
|
2019
|
|
3 |
p. 240-255
|
artikel
|
| 75 |
Outcomes in patients receiving palliative chemotherapy for advanced biliary tract cancer
|
Thol, Felix
|
|
|
|
3 |
p.
|
artikel
|
| 76 |
Patient-reported outcomes with direct-acting antiviral treatment for hepatitis C in West and Central Africa (TAC ANRS 12311 trial)
|
Marcellin, Fabienne
|
|
|
|
3 |
p.
|
artikel
|
| 77 |
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease
|
Boyle, Marie
|
|
2019
|
|
3 |
p. 188-198
|
artikel
|
| 78 |
Physical activity is associated with reduced risk of liver disease in the prospective UK Biobank cohort
|
Schneider, Carolin V.
|
|
|
|
3 |
p.
|
artikel
|
| 79 |
Plasma levels of circulating DNA are associated with outcome, but not with activation of coagulation in decompensated cirrhosis and ACLF
|
Blasi, Annabel
|
|
2019
|
|
3 |
p. 179-187
|
artikel
|
| 80 |
Porto-sinusoidal vascular disorder in chronic HBV: A significant coexistence not to be overlooked
|
Olivas, Pol
|
|
|
|
3 |
p.
|
artikel
|
| 81 |
Potent suppression of hydrophobic bile acids by aldafermin, an FGF19 analogue, across metabolic and cholestatic liver diseases
|
Sanyal, Arun J.
|
|
|
|
3 |
p.
|
artikel
|
| 82 |
Predictive performance of newer Asian hepatocellular carcinoma risk scores in treated Caucasians with chronic hepatitis B
|
Papatheodoridis, George V.
|
|
|
|
3 |
p.
|
artikel
|
| 83 |
Preoperative TIPS prevents the development of postoperative acute-on-chronic liver failure in patients with high CLIF-C AD score
|
Chang, Johannes
|
|
|
|
3 |
p.
|
artikel
|
| 84 |
Primary liver cancer classification from routine tumour biopsy using weakly supervised deep learning
|
Beaufrère, Aurélie
|
|
|
|
3 |
p.
|
artikel
|
| 85 |
Promoter hypermethylation of the AE2/SLC4A2 gene in PBC
|
Arenas, Fabián
|
|
2019
|
|
3 |
p. 145-153
|
artikel
|
| 86 |
Quantitative digital pathology reveals association of cell-specific PNPLA3 transcription with NAFLD disease activity
|
Sandhu, Bynvant
|
|
2019
|
|
3 |
p. 199-202
|
artikel
|
| 87 |
Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in patients following DAA failure
|
Graf, Christiana
|
|
|
|
3 |
p.
|
artikel
|
| 88 |
Rebound of HBV DNA after cessation of nucleos/tide analogues in chronic hepatitis B patients with undetectable covalently closed circular DNA
|
Lai, Ching-Lung
|
|
|
|
3 |
p.
|
artikel
|
| 89 |
Reply to: “Malignant transformation of hepatocellular adenoma”
|
Chopinet, Sophie
|
|
|
|
3 |
p.
|
artikel
|
| 90 |
Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness
|
Dajti, Elton
|
|
|
|
3 |
p.
|
artikel
|
| 91 |
Single-cell RNA sequencing of human liver reveals hepatic stellate cell heterogeneity
|
Payen, Valéry L.
|
|
|
|
3 |
p.
|
artikel
|
| 92 |
Sofosbuvir plus velpatasvir for 8 weeks in patients with acute hepatitis C: The HepNet acute HCV-V study
|
Maasoumy, Benjamin
|
|
|
|
3 |
p.
|
artikel
|
| 93 |
Targeting thrombospondin-2 retards liver fibrosis by inhibiting TLR4-FAK/TGF-β signaling
|
Zhang, Ning
|
|
|
|
3 |
p.
|
artikel
|
| 94 |
Tenofovir use is associated with a decreased risk of hepatocellular carcinoma among men with HIV irrespective of coinfection status
|
Lee, Mei-Hsuan
|
|
|
|
3 |
p.
|
artikel
|
| 95 |
The burden of non-alcoholic steatohepatitis (NASH) among patients from Europe: A real-world patient-reported outcomes study
|
Balp, Maria-Magdalena
|
|
2019
|
|
3 |
p. 154-161
|
artikel
|
| 96 |
The current issue of JHEP Reports
|
Francque, S.
|
|
2019
|
|
3 |
p. 139-141
|
artikel
|
| 97 |
The role of the gut microbiome in chronic liver disease: the clinical evidence revised
|
Schwenger, Katherine JP
|
|
2019
|
|
3 |
p. 214-226
|
artikel
|
| 98 |
TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection
|
Usai, Carla
|
|
|
|
3 |
p.
|
artikel
|
| 99 |
Top level research in hepatology: COVID-19 and beyond
|
Francque, Sven M.A.
|
|
|
|
3 |
p.
|
artikel
|
| 100 |
Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet – a randomised controlled trial
|
Holmer, Magnus
|
|
|
|
3 |
p.
|
artikel
|
| 101 |
Weight-loss-independent benefits of exercise on liver steatosis and stiffness in Japanese men with NAFLD
|
Oh, Sechang
|
|
|
|
3 |
p.
|
artikel
|
| 102 |
Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconverters
|
Lin, Su-Ru
|
|
|
|
3 |
p.
|
artikel
|
Tijdschrift beschrijving